Wolfson Institute of Preventive Medicine

2008

We maintain an archive of past and current publications which can be searched by clicking on the links to the left or by using the drop down menus at the top of this page to search by author name, journal name or year of publication.

Alternatively you can use the search bar to look up a key word.

Our most recent publications are listed below.

AuthorsPublication SummaryJournalYears
Nazarenko I,Kobayashi L,Giles J,Fishman C,Chen G,Lorincz A A novel method of HPV genotyping using Hybrid Capture sample preparation method combined with GP5+/6+ PCR and multiplex detection on Luminex XMAP.. vol.154, (1-2) 76.
10.1016/j.jviromet.2008.09.002
J Virol Methods 2008
Curtis D,Vine AE,Knight J A simple method for assessing the strength of evidence for association at the level of the whole gene. vol.1, (1) 115.
doi
Advances and Applications in Bioinformatics and Chemistry 2008
Brain K,Henderson BJ,Tyndel S,Bankhead C,Watson E,Clements A,Austoker J,PIMMS Study Management Group null Predictors of breast cancer-related distress following mammography screening in younger women on a family history breast screening programme.. vol.17, (12) 1180.
10.1002/pon.1355
Psychooncology 2008
Wald NJ,Morris JK,Walker K,Simpson JM Prenatal screening for serious congenital heart defects using nuchal translucency: a meta-analysis.. vol.28, (12) 1094.
10.1002/pd.2124
Prenat Diagn 2008
Glover M,McRobbie H Smoking cessation. vol.volume, (issue) 37.
10.1016/B978-012373960-5.00351-8
journal 2008
Cuzick J,Sestak I,Cella D,Fallowfield L,ATAC Trialists' Group null Treatment-emergent endocrine symptoms and the risk of breast cancer recurrence: a retrospective analysis of the ATAC trial.. vol.9, (12) 1143.
10.1016/S1470-2045(08)70259-6
Lancet Oncol 2008
Hajek P [Commentary] IS THIS A BREAKTHROUGH IN PSYCHOLOGICAL TREATMENT OF ADDICTION, OR ARE MOMMY AND I ONE AGAIN?. vol.103, (12) 2032.
10.1111/j.1360-0443.2008.02400.x
ADDICTION 2008
Vickaryous N,Polanco-Echeverry G,Morrow S,Suraweera N,Thomas H,Tomlinson I,Silver A Smooth-muscle myosin mutations in hereditary non-polyposis colorectal cancer syndrome.. vol.99, (10) 1726.
10.1038/sj.bjc.6604737
Br J Cancer 2008
Sherrill B,Amonkar M,Wu Y,Hirst C,Stein S,Walker M,Cuzick J Relationship between effects on time-to-disease progression and overall survival in studies of metastatic breast cancer. vol.99, (10) 1572.
10.1038/sj.bjc.6604759
BRIT J CANCER 2008
Wald DS,Law M,Mills S,Bestwick JP,Morris JK,Wald NJ A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a beta-blocker on blood pressure reduction.. vol.30, (11) 2030.
10.1016/j.clinthera.2008.11.003
Clin Ther 2008
Churchman SM,Church LD,Savic S,Coulthard LR,Hayward B,Nedjai B,Turner MD,Mathews RJ,Baguley E,Hitman GA,Gooi HC,Wood PMD,Emery P,McDermott MF A novel TNFRSF1A splice mutation associated with increased nuclear factor kappa appaB (NF-kappa B) transcription factor activation in patients with tumour necrosis factor receptor associated periodic syndrome (TRAPS). vol.67, (11) 1589.
10.1136/ard.2007.078667
ANN RHEUM DIS 2008
Szarewski A,Ambroisine L,Cadman L,Austin J,Ho L,Terry G,Liddle S,Dina R,McCarthy J,Buckley H,Bergeron C,Soutter P,Lyons D,Cuzick J Comparison of predictors for high-grade cervical intraepithelial neoplasia in women with abnormal smears.. vol.17, (11) 3033.
10.1158/1055-9965.EPI-08-0508
Cancer Epidemiol Biomarkers Prev 2008
McRobbie H,Hajek P,Locker J Does the reaction of abstaining smokers to the smell of other people's cigarettes predict relapse?. vol.103, (11) 1883.
10.1111/j.1360-0443.2008.02340.x
ADDICTION 2008
Clark J,Attard G,Ambroisine L,Mills IG,Fisher G,Flohr P,Reid A,Edwards S,Kovacs G,Berney D,Foster C,Massie CE,Fletcher A,De Bono JS,Scardino P,Cuzick J,Cooper CS,Transatlantic-Prostate-Grp null ETS GENE TRANSLOCATIONS AND PROSTATE CANCER PROGNOSIS. vol.28, (6B) 4155.
doi
ANTICANCER RES 2008
Cuzick J Hormone replacement therapy and the risk of breast cancer.. vol.44, (16) 2344.
10.1016/j.ejca.2008.07.041
Eur J Cancer 2008
Bowers L,Whittington R,Nolan P,Parkin D,Curtis S,Bhui K,Hackney D,Allan T,Simpson A Relationship between service ecology, special observation and self-harm during acute in-patient care: City-128 study. vol.193, (5) 395.
10.1192/bjp.bp.107.037721
BRIT J PSYCHIAT 2008
McKenzie K,Bhui K,Nanchahal K,Blizard B Suicide rates in people of South Asian origin in England and Wales: 1993-2003. vol.193, (5) 406.
10.1192/bjp.bp.107.042598
BRIT J PSYCHIAT 2008
Dillner J,Rebolj M,Birembaut P,Petry KU,Szarewski A,Munk C,De Sanjose S,Naucler P,Lloveras B,Kjaer S,Cuzick J,Van Ballegooijen M,Clavel C,Iftner T Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: Joint European cohort study. vol.337, (7676) 969.
10.1136/bmj.a1662
BMJ 2008
Gilbert FJ,Astley SM,Gillan MGC,Agbaje OF,Wallis MG,James J,Boggis CRM,Duffy SW,CADET II Grp null Single reading with computer-aided detection for screening mammography. vol.359, (16) 1675.
10.1056/NEJMoa0803545
NEW ENGL J MED 2008
Thorat MA,Rangole A,Nadkarni MS,Parmar V,Badwe RA Revision surgery for breast cancer: Single-institution experience. vol.113, (8 SUPPL.) 2347.
10.1002/cncr.23839
Cancer 2008
Dillner J,Rebolj M,Birembaut P,Petry K-U,Szarewski A,Munk C,de Sanjose S,Naucler P,Lloveras B,Kjaer S,Cuzick J,van Ballegooijen M,Clavel C,Iftner T,Joint European Cohort Study null Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study.. vol.337, (issue) a1754.
10.1136/bmj.a1754
BMJ 2008
Duffy SW,Lynge E,Jonsson H,Ayyaz S,Olsen AH Complexities in the estimation of overdiagnosis in breast cancer screening.. vol.99, (7) 1176.
10.1038/sj.bjc.6604638
Br J Cancer 2008
Caulfield MJ,Munroe PB,O'Neill D,Witkowska K,Charchar FJ,Doblado M,Evans S,Eyheramendy S,Onipinla A,Howard P,Shaw-Hawkins S,Dobson RJ,Wallace C,Newhouse SJ,Brown M,Connell JM,Dominiczak A,Farrall M,Lathrop GM,Samani NJ,Kumari M,Marmot M,Brunner E,Chambers J,Elliott P,Kooner J,Laan M,Org E,Veldre G,Viigimaa M,Cappuccio FP,Ji C,Iacone R,Strazzullo P,Moley KH,Cheeseman C SLC2A9 is a high-capacity urate transporter in humans.. vol.5, (10) e197.
10.1371/journal.pmed.0050197
PLoS Med 2008
Smith RA,Field JK,Duffy SW A global approach to cancer-screening trials. vol.9, (10) 908.
10.1016/S1470-2045(08)70211-0
LANCET ONCOL 2008
Qiao Y-L,Sellors JW,Eder PS,Bao Y-P,Lim JM,Zhao F-H,Weigl B,Zhang W-H,Peck RB,Li L,Chen F,Pan Q-J,Lorincz AT A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China.. vol.9, (10) 929.
10.1016/S1470-2045(08)70210-9
Lancet Oncol 2008
Kudahetti S,Fisher G,Ambroidine I,Kattan M,Foster C,Oliver T,Moller H,Reuter V,Fearn P,Eastham J,Scardino P,Cuzick J,Berney D Cell-cycle proteins as biomarkers in clinically localised prostate cancer patients managed conservatively-results from the trans-atlantic prostate group. vol.53, (issue) 279.
doi
HISTOPATHOLOGY 2008
Puri V,McQuillin A,Datta S,Choudhury K,Pimm J,Thirumalai S,Krasucki R,Lawrence J,Quested D,Bass N,Crombie C,Fraser G,Walker N,Moorey H,Ray MK,Sule A,Curtis D,Clair DS,Gurling H Confirmation of the genetic association between the U2AF homology motif (UHM) kinase 1 (UHMK1) gene and schizophrenia on chromosome 1q23.3. vol.16, (10) 1275.
10.1038/ejhg.2008.76
EUR J HUM GENET 2008
Badve S,Thorat M,Reis-Filho J Cytoplasmic expression of ALDH1 correlates with breast cancer subtypes. vol.53, (issue) 26.
doi
HISTOPATHOLOGY 2008
Jenkins VA,Ambroisine LM,Atkins L,Cuzick J,Howell A,Fallowfield LJ Effects of anastrozole on cognitive performance in postmenopausal women: a randomised, double-blind chemoprevention trial (IBIS II).. vol.9, (10) 953.
10.1016/S1470-2045(08)70207-9
Lancet Oncol 2008
Resetkova E,Thorat M,Badve S Expression of ALDH1 (putative cancer stem cell marker) does not correlate with response to neoadjuvant chemotherapy (NACT) in breast carcinoma. vol.53, (issue) 59.
doi
HISTOPATHOLOGY 2008
Brown MJ,Newhouse S,Wallace C,Marcano AC,Shaw-Hawkins S,Howard P,Onipinla A,Dobson R,Mein C,Lee W,Delles C,Padmanabhan S,Dominiczak AF,Samani NJ,Webster J,Lathrop M,Farrall M,Connell JMC,Caulfield MJ,Monroe PB Systematic analysis of 123 candidate genes reveals two novel genes for hypertension. vol.52, (4) 764.
doi
HYPERTENSION 2008
Carozzi F,Confortini M,Dalla Palma P,Del Mistro A,Gillio-Tos A,De Marco L,Giorgi-Rossi P,Pontenani G,Rosso S,Sani C,Sintoni C,Segnan N,Zorzi M,Cuzick J,Rizzolo R,Ronco G,New Technologies for Cervival Cancer Screening (NTCC) Working Group null Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trial.. vol.9, (10) 937.
10.1016/S1470-2045(08)70208-0
Lancet Oncol 2008
Curtis D Antipsychotics and stroke risk: Effect of antipsychotics on stroke risk remains unproved. vol.337, (7671) 647.
doi
BMJ 2008
Curtis D Effect of antipsychotics on stroke risk remains unproved.. vol.337, (issue) a1673.
10.1136/bmj.a1673
BMJ 2008
International Schizophrenia Consortium null Rare chromosomal deletions and duplications increase risk of schizophrenia.. vol.455, (7210) 237.
10.1038/nature07239
Nature 2008
Gaysina D,Cohen S,Craddock N,Farmer A,Hoda F,Korszun A,Owen MJ,Craig IW,McGuffin P No association with the 5,10-methylenetetrahydrofolate reductase gene and major depressive disorder: Results of the depression case control (DeCC) study and a meta-analysis. vol.147B, (6) 699.
10.1002/ajmg.b.30665
AM J MED GENET B 2008
Oliver T,Lorincz A,Cuzick J CHEMO-PREVENTION OF: PROSTATE CANCER: THE RATIONALE BEHIND DESIGN OF PILOT STUDIES. vol.28, (5C) 3428.
doi
ANTICANCER RES 2008
Knight J,Curtis D,Sham PC CLUMPHAP: A simple tool for performing haplotype-based association analysis. vol.32, (6) 539.
10.1002/gepi.20327
GENET EPIDEMIOL 2008
Ferreira MAR,O'Donovan MC,Meng YA,Jones IR,Ruderfer DM,Jones L,Fan J,Kirov G,Perlis RH,Green EK,Smoller JW,Grozeva D,Stone J,Nikolov I,Chambert K,Hamshere ML,Nimgaonkar VL,Moskvina V,Thase ME,Caesar S,Sachs GS,Franklin J,Gordon-Smith K,Ardlie KG,Gabriel SB,Fraser C,Blumenstiel B,Defelice M,Breen G,Gill M,Morris DW,Elkin A,Muir WJ,McGhee KA,Williamson R,MacIntyre DJ,MacLean AW,St CD,Robinson M,Van Beck M,Pereira ACP,Kandaswamy R,McQuillin A,Collier DA,Bass NJ,Young AH,Lawrence J,Ferrier IN,Anjorin A,Farmer A,Curtis D,Scolnick EM,McGuffin P,Daly MJ,Corvin AP,Holmans PA,Blackwood DH,Gurling HM,Owen MJ,Purcell SM,Sklar P,Craddock N,Wellcome Trust Case Control Consortium null Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder.. vol.40, (9) 1056.
10.1038/ng.209
Nat Genet 2008
Cuzick JM DETERMINING THE OPTIMAL TIMING AND DURATION OF THE USE OF AN AROMATASE INHIBITOR (AI) IN THE ADJUVANT TREATMENT OF POSTMENOPAUSAL HORMONE RECEPTOR-POSITIVE (HR plus ) BREAST CANCER (BC) USING MODELLING ANALYSES. vol.19, (issue) 87.
doi
ANNALS OF ONCOLOGY 2008
Thorat MA,Badve S Estrogen- and progesterone-receptor status in breast cancer: Immunohistochemistry and quantitative reverse transcription-polymerase chain reaction assays show equivalency. vol.7, (9) paginationBegin.
doi
American Journal of Hematology/ Oncology 2008
Cuzick J IBIS II: a breast cancer prevention trial in postmenopausal women using the aromatase inhibitor anastrozole.. vol.8, (9) 1377.
10.1586/14737140.8.9.1377
Expert Rev Anticancer Ther 2008
Sestak I,Cuzick J,Sapunar F,Eastell R,Forbes JF,Bianco AR,Buzdar AU,ATAC Trialists' Group null Risk factors for joint symptoms in patients enrolled in the ATAC trial: a retrospective, exploratory analysis.. vol.9, (9) 866.
10.1016/S1470-2045(08)70182-7
Lancet Oncol 2008
Hajek P,Tonnesen P,Russ C,Arteaga C,Tonstad S Which smokers are most likely to benefit from extended treatment with varenicline?. vol.29, (issue) 700.
doi
EUROPEAN HEART JOURNAL 2008
Wald D Commentary: Controversies in NICE guidance on familial hypercholesterolaemia.. vol.337, (issue) a1304.
10.1136/bmj.a1304
BMJ 2008
Duffy SW,Bowen RL,Ryan DA,Hart IR,Jones JL Reply: Early onset of breast cancer in black British women: how reliable are the findings?. vol.volume, (issue) paginationBegin.
10.1038/sj.bjc.6604626
Br J Cancer 2008
Cuzick J,Arbyn M,Sankaranarayanan R,Tsu V,Ronco G,Mayrand M-H,Dillner J,Meijer CJLM Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.. vol.26 Suppl 10, (issue) K29.
10.1016/j.vaccine.2008.06.019
Vaccine 2008
Garland SM,Cuzick J,Domingo EJ,Goldie SJ,Kim Y-T,Konno R,Parkin DM,Qiao Y-L,Sankaranarayanan R,Stern PL,Tay SK,Bosch FX Recommendations for cervical cancer prevention in Asia Pacific.. vol.26 Suppl 12, (issue) M89.
10.1016/j.vaccine.2008.06.020
Vaccine 2008
Wald NJ,Bestwick JP,Canick JA Contingent screening for Down syndrome.. vol.28, (8) 781.
10.1002/pd.2032
Prenat Diagn 2008
Field JK,Duffy SW Lung cancer screening: the way forward. vol.99, (4) 557.
10.1038/sj.bjc.6604509
BRIT J CANCER 2008
Cuzick J Use of LHRH-agonists as adjuvant therapy for breast cancer.. vol.12, (8) 1065.
10.1517/14728222.12.8.1065
Expert Opin Ther Targets 2008
Ciatto S,Houssami N,Martinelli F,Bonardi R,Cafferty FH,Duffy SW Second breast cancers in a Tuscan case series: characteristics, prognosis, and predictors of survival. vol.99, (3) 539.
10.1038/sj.bjc.6604481
BRIT J CANCER 2008
Attard G,Clark J,Ambroisine L,Mills IG,Fisher G,Flohr P,Reid A,Edwards S,Kovacs G,Berney D,Foster C,Massie CE,Fletcher A,De Bono JS,Scardino P,Cuzick J,Cooper CS,Transatlantic Prostate Group null Heterogeneity and clinical significance of ETV1 translocations in human prostate cancer.. vol.99, (2) 314.
10.1038/sj.bjc.6604472
Br J Cancer 2008
SESTAK I Breast Cancer Chemoprevention: A Risk-benefit Profile for Tamoxifen and Anastrozole. vol.volume, (issue) paginationBegin.
doi
journal 2008
Turner MD,Nedjai B,Hitman GA,McDermott M Cell surface expression of TNFRI in tumor necrosis factor receptor-associated periodic syndrome: comment on the article by Nedjai et al - Reply. vol.58, (7) 2214.
10.1002/art.23547
ARTHRITIS RHEUM 2008
Duffy SW,Nagtegaal ID,Wallis M,Cafferty FH,Houssami N,Warwick J,Allgood PC,Kearins O,Tappenden N,O'Sullivan E,Lawrence G Correcting for lead time and length bias in estimating the effect of screen detection on cancer survival.. vol.168, (1) 98.
10.1093/aje/kwn120
Am J Epidemiol 2008
Curtis D,Vine AE,Knight J Investigation into the ability of SNP chipsets and microsatellites to detect association with a disease locus.. vol.72, (Pt 4) 547.
10.1111/j.1469-1809.2008.00434.x
Ann Hum Genet 2008
Cuzick J Primary endpoints for randomised trials of cancer therapy.. vol.371, (9631) 2156.
10.1016/S0140-6736(08)60933-2
Lancet 2008
McRobbie H,Bullen C,Glover M,Whittaker R,Wallace-Bell M,Fraser T,New Zealand Guidelines Group null New Zealand smoking cessation guidelines.. vol.121, (1276) 57.
doi
N Z Med J 2008
Bullen C,Walker N,Whittaker R,McRobbie H,Glover M,Fraser T Smoking cessation competencies for health workers in New Zealand.. vol.121, (1276) 48.
doi
N Z Med J 2008
Bowen RL,Duffy SW,Ryan DA,Hart IR,Jones JL Reply: Early onset of breast cancer in British black women. vol.98, (12) 2012.
10.1038/sj.bjc.6604416
British Journal of Cancer 2008
RĂ¼dell K,Bhui K,Priebe S Do 'alternative' help-seeking strategies affect primary care service use? A survey of help-seeking for mental distress.. vol.8, (issue) 207.
10.1186/1471-2458-8-207
BMC Public Health 2008
Bowen RL,Duffy SW,Ryan DA,Hart IR,Jones JL Early onset of breast cancer in British black women - Reply. vol.98, (12) 2012.
10.1038/sj.bjc.6604416
BRIT J CANCER 2008
McRobbie H,Hajek P,Feder G,Eldridge S A cluster-randomised controlled trial of a brief training session to facilitate general practitioner referral to smoking cessation treatment. vol.17, (3) 173.
10.1136/tc.2008.024802
TOB CONTROL 2008
Forbes JF,Cuzick J,Buzdar A,Howell A,Baum M,ATAC Trialists Grp null ATAC: 100 month median follow-up (FU) shows continued superior efficacy and no excess fracture risk for anastrozole (A) compared with tamoxifen (T) after treatment completion. vol.109, (3) 590.
doi
BREAST CANCER RESEARCH AND TREATMENT 2008
Poller L,Keown M,Ibrahim S,Lowe G,Moia M,Turpie AG,Roberts C,Van den Besselaar AMHP,Van der Meer FJM,Tripodi A,Palareti G,Shiach C,Bryan S,Samama M,Burgess-Wilson M,Heagerty A,Maccallum P,Wright D,Jespersen J An international multicenter randomized study of computer-assisted oral anticoagulant dosage vs. medical staff dosage. vol.6, (6) 935.
10.1111/j.1538-7836.2008.02959.x
J THROMB HAEMOST 2008
Sklar P,Smoller JW,Fan J,Ferreira MAR,Perlis RH,Chambert K,Nimgaonkar VL,McQueen MB,Faraone SV,Kirby A,de Bakker PIW,Ogdie MN,Thase ME,Sachs GS,Todd-Brown K,Gabriel SB,Sougnez C,Gates C,Blumenstiel B,Defelice M,Ardlie KG,Franklin J,Muir WJ,McGhee KA,MacIntyre DJ,McLean A,VanBeck M,McQuillin A,Bass NJ,Robinson M,Lawrence J,Anjorin A,Curtis D,Scolnick EM,Daly MJ,Blackwood DH,Gurling HM,Purcell SM Whole-genome association study of bipolar disorder.. vol.13, (6) 558.
10.1038/sj.mp.4002151
Mol Psychiatry 2008
McRobbie H,Thornley S [The importance of treating tobacco dependence].. vol.61, (6) 620.
10.1157/13123068
Rev Esp Cardiol 2008
Wishart GC,Greenberg DC,Britton PD,Chou P,Brown CH,Purushotham AD,Duffy SW Screen-detected vs symptomatic breast cancer: is improved survival due to stage migration alone?. vol.98, (11) 1741.
10.1038/sj.bjc.6604368
BRIT J CANCER 2008
Gilbert FJ,Astley SM,Gillan MG,Agbaje OF,Wallis MG,James J,Boggis CR,Duffy SW,Grp CADETII CADET II: A prospective trial of computer-aided detection (CAD) in the UK Breast Screening Programme. vol.26, (15) paginationBegin.
10.1200/jco.2008.26.15_suppl.508
JOURNAL OF CLINICAL ONCOLOGY 2008
Duchnowska R,Jassem J,Thorat MA,Morimiya A,Sledge GW,Li L,Biernat W,Szczylik C,Steeg PS,Badve SS Gene expression analysis for prediction of early brain metastasis (BM) in HER2-positive (HER2+) breast cancer patients (pts). vol.26, (15) paginationBegin.
10.1200/jco.2008.26.15_suppl.1019
JOURNAL OF CLINICAL ONCOLOGY 2008
Duchnowska R,Jassem J,Thorat MA,Morimiya A,Sledge GW,Li L,Biernat W,Szczylik C,Steeg PS,Badve SS Gene expression analysis for prediction of early brain metastasis (BM) in HER2-positive (HER2+) breast cancer patients (pts).. vol.26, (15_suppl) 1019.
doi
J Clin Oncol 2008
Buzdar AU,Cuzick J Is overall survival an appropriate endpoint in early breast cancer studies? Data from the ATAC study at 100-month median follow-up. vol.26, (15) paginationBegin.
10.1200/jco.2008.26.15_suppl.552
JOURNAL OF CLINICAL ONCOLOGY 2008
Thorat MA,Saxena R,Badve SS Regulatory T cells (T-Regs) in breast cancer sentinel nodes (SN): FOXP3 expression analysis. vol.26, (15) paginationBegin.
10.1200/jco.2008.26.15_suppl.22175
JOURNAL OF CLINICAL ONCOLOGY 2008
Thorat MA,Saxena R,Badve SS Regulatory T cells (T-Regs) in breast cancer sentinel nodes (SN): FOXP3 expression analysis.. vol.26, (15_suppl) 22175.
doi
J Clin Oncol 2008
Grimison PS,Coates AS,Forbes JF,Cuzick J,Furnival C,Craft PS,Snyder RD,Thornton RM,Lindsay DF,Simes RJ,Canc ANZB Tamoxifen (TAM) for the prevention of breast cancer: Importance of specific aspects of health-related quality of life (HRQL) to global health status in the ANZ BCTG substudy of IBIS-1 (ANZ 92P1). vol.26, (15) paginationBegin.
10.1200/jco.2008.26.15_suppl.1516
JOURNAL OF CLINICAL ONCOLOGY 2008
Cuzick J,Szarewski A,Mesher D,Cadman L,Austin J,Perryman K,Ho L,Terry G,Sasieni P,Dina R,Soutter WP Long-term follow-up of cervical abnormalities among women screened by HPV testing and cytology-Results from the Hammersmith study.. vol.122, (10) 2294.
10.1002/ijc.23339
Int J Cancer 2008
Cuzick J Review of Swedish cervical cancer screening program demonstrates effectiveness and room for improvement. vol.100, (9) 602.
doi
J NATL CANCER I 2008
Cuzick J Routine audit of large-scale cervical cancer screening programs.. vol.100, (9) 605.
10.1093/jnci/djn131
J Natl Cancer Inst 2008
Bhui K,Khatib Y,Viner R,Klineberg E,Clark C,Head J,Stansfeld S Cultural identity, clothing and common mental disorder: a prospective school-based study of white British and Bangladeshi adolescents.. vol.62, (5) 435.
10.1136/jech.2007.063149
J Epidemiol Community Health 2008
Perry NM,Allgood PC,Duffy SW,Mokbel K Exposure to traffic emissions throughout life and risk of breast cancer.. vol.19, (4) 435.
10.1007/s10552-007-9101-x
Cancer Causes Control 2008
Rowe R,Rijsdijk FV,Maughan B,Eley TC,Hosang GM,Eley TC Heterogeneity in antisocial behaviours and comorbidity with depressed mood: a behavioural genetic approach.. vol.49, (5) 526.
10.1111/j.1469-7610.2008.01834.x
J Child Psychol Psychiatry 2008
Viner RM,Clark C,Taylor SJC,Bhui K,Klineberg E,Head J,Booy R,Stansfeld SA Longitudinal risk factors for persistent fatigue in adolescents. vol.162, (5) 469.
10.1001/archpedi.162.5.469
ARCH PEDIAT ADOL MED 2008
Farmer A,Korszun A,Owen MJ,Craddock N,Jones L,Jones I,Gray J,Williamson RJ,McGuffin P Medical disorders in people with recurrent depression.. vol.192, (5) 351.
10.1192/bjp.bp.107.038380
Br J Psychiatry 2008
Archer J,Hutchison I,Korszun A Mood and malignancy: head and neck cancer and depression.. vol.37, (5) 255.
10.1111/j.1600-0714.2008.00635.x
J Oral Pathol Med 2008
McEwen A,West R,McRobbie H Motives for smoking and their correlates in clients attending Stop Smoking treatment services.. vol.10, (5) 843.
10.1080/14622200802027248
Nicotine Tob Res 2008
Bowen R,Duffy S,Ryan D,Hart I,Jones L Reply: Early onset breast cancer in black British women: a letter to the editor of British Journal of Cancer regarding early onset of breast cancer in a group of British black women. vol.98, (8) 1483.
10.1038/sj.bjc.6604337
BRIT J CANCER 2008
Bayston R,Russell A,Wald NJ,Hoffbrand AV Folic acid fortification and cancer risk - Authors' reply. vol.371, (9621) 1335.
10.1016/S0140-6736(08)60591-7
Lancet 2008
Law M,Wald N Cholesterol, statins, and mortality.. vol.371, (9619) 1161.
10.1016/S0140-6736(08)60516-4
Lancet 2008
Ronco G,Giorgi-Rossi P,Carozzi F,Confortini M,Dalla Palma P,Del Mistro A,Gillio-Tos A,Minucci D,Naldoni C,Rizzolo R,Schincaglia P,Volante R,Zappa M,Zorzi M,Cuzick J,Segnan N,New Technologies for Cervical Cancer Screening Working Group null Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test.. vol.100, (7) 492.
10.1093/jnci/djn065
J Natl Cancer Inst 2008
McRobbie H,Barlow D,Bullen C,Eadie S,Wallace-Bell M,Whittaker R An Evaluation of the Activity of Smoking Cessation Practitioners in New Zealand Following Smoking Cessation Training. vol.3, (1) 35.
10.1375/jsc.3.1.35
Journal of Smoking Cessation 2008
Cuzick J Aromatase inhibitors in early breast-cancer treatment: The story so far.. vol.17 Suppl 3, (issue) S2.
10.1016/j.breast.2007.12.002
Breast 2008
Cooke F,Bullen C,Whittaker R,McRobbie H,Chen M-H,Walker N Diagnostic accuracy of NicAlert cotinine test strips in saliva for verifying smoking status.. vol.10, (4) 607.
10.1080/14622200801978680
Nicotine Tob Res 2008
Sherrill B,Amonkar M,Wu Y,Hirst C,Stein S,Walkers M,Cuzick J Disease progression as a predictor of overall survival in metastatic breast cancer: a meta-analysis. vol.6, (7) 216.
10.1016/S1359-6349(08)70880-2
EJC SUPPLEMENTS 2008
Syrjanen K,Naud P,Derchain S,Roteli-Martins C,Longatto A,Tatti S,Branca M,Erzen M,Hammes LS,Matos J,Gontijo R,Sarian L,Braganga J,Arlindo FC,Maeda MYS,Lorincz A,Dores GB,Costa S,Syrjanen S Drug addiction is not an independent risk factor for oncogenic human papillomavirus infections or high-grade cervical intraepithelial neoplasia: case-control study nested within the Latin American Screening study cohort. vol.19, (4) 251.
10.1258/ijsa.2007.007179
INT J STD AIDS 2008
Bhui K,King M,Dein S,O'Connor W Ethnicity and religious coping with mental distress. vol.17, (2) 141.
10.1080/09638230701498408
J MENT HEALTH 2008
Wald NJ,Huttly WJ,Bestwick JP Inhibin-A concentrations between 14 and 22 weeks of gestation.. vol.28, (4) 360.
10.1002/pd.1964
Prenat Diagn 2008
Duffy S,Blamey RW,UKCCCR Breast Cancer Frequency Tri null Long-term mortality results from the UK Breast Screening Frequency Trial. vol.6, (7) 48.
10.1016/S1359-6349(08)70316-1
EJC SUPPLEMENTS 2008
Cuzick J Optimal timing and duration of the use of an aromatase inhibitor (AI) in the adjuvant treatment of postmenopausal hormone receptor-positive (HR+) breast cancer (BC). vol.6, (7) 121.
10.1016/S1359-6349(08)70562-7
EJC SUPPLEMENTS 2008
Madhani M,Pasi KJ,Gutteridge CN,Ratnasabapathy S,Kakkar AK,MacCallum PK Preventing venous thromboembolism (VTE) in hospitalised patients: putting guidance into practice. vol.141, (issue) 83.
doi
BRITISH JOURNAL OF HAEMATOLOGY 2008
Bhui KS,McKenzie K Rates and risk factors by ethnic group for suicides within a year of contact with mental health services in England and Wales.. vol.59, (4) 414.
10.1176/ps.2008.59.4.414
Psychiatr Serv 2008
Bullen C,Howe C,Grigg M,Phillips F,Silcock R,Glover M,McRobbie H,Whittaker R Recruitment into a Cessation Trial Via the New Zealand Quitline: Many Benefits, Few Limitations. vol.3, (1) 30.
10.1375/jsc.3.1.30
Journal of Smoking Cessation 2008
Sestak I,Forbes JF,Edwards R,Howell A,Cuzick J Timing and severity of prominent side effects of anastrozole and tamoxifen. vol.6, (7) 71.
10.1016/S1359-6349(08)70389-6
EJC SUPPLEMENTS 2008
Clark J,Attard G,Jhavar S,Flohr P,Reid A,De-Bono J,Eeles R,Scardino P,Cuzick J,Fisher G,Parker MD,Foster CS,Berney D,Kovacs G,Cooper CS Complex patterns of ETS gene alteration arise during cancer development in the human prostate.. vol.27, (14) 1993.
10.1038/sj.onc.1210843
Oncogene 2008
Franco EL,Cuzick J Cervical cancer screening following prophylactic human papillomavirus vaccination.. vol.26 Suppl 1, (issue) A16.
10.1016/j.vaccine.2007.11.069
Vaccine 2008
Pal A,Provenzano E,Duffy SW,Pinderl SE,Purushotham AD A model for predicting non-sentinel lymph node metastatic disease when the sentinel lymph node is positive. vol.95, (3) 302.
10.1002/bjs.5943
BRIT J SURG 2008
Nedjai B,Hitman G,Yousaf N,Chernajovsky Y,Stjernberg-Salmela S,Pettersson T,Ranki A,Hawkins P,Arkwright P,McDermott M,Turner M Abnormal TNFR1 cell surface expression and NF-kappaB activation in TNFR1-Associated Periodic Fever Syndrome (TRAPS). vol.26, (2) 182.
doi
CLIN EXP RHEUMATOL 2008
Korszun A Cardiovascular risk and metabolic syndrome in depression - Connections and directions. vol.107, (issue) S24.
10.1016/j.jad.2007.12.155
J AFFECT DISORDERS 2008
Eastell R,Adams JE,Coleman RE,Howell A,Hannon RA,Cuzick J,Mackey JR,Beckmann MW,Clack G Effect of anastrozole on bone mineral density: 5-year results from the anastrozole, tamoxifen, alone or in combination trial 18233230.. vol.26, (7) 1051.
10.1200/JCO.2007.11.0726
J Clin Oncol 2008
Korszun A Pathophysiological links between stress, depression and CHD. vol.107, (issue) S24.
10.1016/j.jad.2007.12.157
J AFFECT DISORDERS 2008
Oliver RTD,Lorincz A,Cuzick J Prostate cancer prevention by short-term antiandrogens: A novel strategy. vol.6, (3) 32.
10.1016/S1359-6349(08)70224-6
EJC SUPPLEMENTS 2008
Dowsett M,Allred C,Knox J,Quinn E,Salter J,Wale C,Cuzick J,Houghton J,Williams N,Mallon E,Bishop H,Ellis I,Larsimont D,Sasano H,Carder P,Cussac AL,Knox F,Speirs V,Forbes J,Buzdar A Relationship between quantitative estrogen and progesterone receptor expression and human epidermal growth factor receptor 2 (HER-2) status with recurrence in the Arimidex, Tamoxifen, Alone or in Combination trial.. vol.26, (7) 1059.
10.1200/JCO.2007.12.9437
J Clin Oncol 2008
Curtis D,Vine AE,Knight J Study of regions of extended homozygosity provides a powerful method to explore haplotype structure of human populations.. vol.72, (Pt 2) 261.
10.1111/j.1469-1809.2007.00411.x
Ann Hum Genet 2008
Cohen S,Pirlo K,Schosser A,Gaysina D,Craddock N,Korszun A,Owen M,Craig I,Farmer A,McGuffin P The depression case control study in the whole genome association era: results and implications for the future. vol.18, (issue) S9.
10.1016/S0924-977X(08)70011-7
EUROPEAN NEUROPSYCHOPHARMACOLOGY 2008
Cuzick J Use of aromatase inhibitors in breast cancer prevention. vol.6, (3) 21.
10.1016/S1359-6349(08)70213-1
EJC SUPPLEMENTS 2008
Wald NJ,Morris JK,Young NJ,Wald DS Meta-analysis audit trail. vol.371, (9612) 558.
10.1016/S0140-6736(08)60266-4
LANCET 2008
Wald NJ,Morris JK,Young NJ,Wald DS Meta-analysis audit trail.. vol.371, (9612) 558.
10.1016/S0140-6736(08)60266-4
Lancet 2008
Persaud AC,Elgie R,Lynch E,Bhui K Cultural competence in assessing and diagnosing bipolar disorder improves outcomes. vol.10, (issue) 10.
doi
BIPOLAR DISORDERS 2008
Eastham JA,Kattan MW,Fearn P,Fisher G,Berney DM,Oliver T,Foster CS,Moller H,Reuter V,Cuzick J,Scardino P,Transatlantic Prostate Grp null Local progression among men with conservatively treated localized prostate cancer: Results from the transatlantic prostate group. vol.53, (2) 347.
10.1016/j.eururo.2007.05.015
EUR UROL 2008
Perry NM,Allgood PC,Milner SE,Mokbel K,Duffy SW Mammographic breast density by area of residence: possible evidence of higher density in urban areas. vol.24, (2) 365.
10.1185/030079908X260907
CURR MED RES OPIN 2008
Bowen RL,Duffy SW,Ryan DA,Hart IR,Jones JL Early onset of breast cancer in a group of British black women.. vol.98, (2) 277.
10.1038/sj.bjc.6604174
Br J Cancer 2008
Cassidy A,Myles JP,van Tongeren M,Page RD,Liloglou T,Duffy SW,Field JK The LLP risk model: an individual risk prediction model for lung cancer. vol.98, (2) 270.
10.1038/sj.bjc.6604158
BRIT J CANCER 2008
McEwen A,Hajek P,McRobbie H,West R Manual of Smoking Cessation: A Guide For Counsellors and Practitioners. vol.volume, (issue) 1.
10.1002/9780470757864
Manual of Smoking Cessation: A Guide For Counsellors and Practitioners 2008
Allgood PC,Warwick J,Warren RML,Day NE,Duffy SW A case-control study of the impact of the East Anglian breast screening programme on breast cancer mortality.. vol.98, (1) 206.
10.1038/sj.bjc.6604123
Br J Cancer 2008
Attard G,Clark J,Ambroisine L,Fisher G,Kovacs G,Flohr P,Berney D,Foster CS,Fletcher A,Gerald WL,Moller H,Reuter V,De Bono JS,Scardino P,Cuzick J,Cooper CS,Transatlantic Prostate Group null Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer.. vol.27, (3) 253.
10.1038/sj.onc.1210640
Oncogene 2008
Whittaker R,Maddison R,McRobbie H,Bullen C,Denny S,Dorey E,Ellis-Pegler M,van Rooynen J,Rodgers A A multimedia mobile phone-based youth smoking cessation intervention: findings from content development and piloting studies. vol.10, (5) paginationBegin.
10.2196/jmir.1007
J Med Internet Res 2008
Curtis D,Vine AE,Knight J A simple method for assessing the strength of evidence for association at the level of the whole gene.. vol.1, (issue) 115.
10.2147/AABC.S4095
Adv Appl Bioinform Chem 2008
Nedjai B,Hitman GA,Yousaf N,Chernajovsky Y,Stiernberg-Salmela S,Pettersson T,Ranki A,Hawkins PN,Arkwright PD,McDermott MF,Turner MD Abnormal tumor necrosis factor receptor I cell surface expression and NF-kappa B activation in tumor necrosis factor receptor-associated periodic syndrome. vol.58, (1) 273.
10.1002/art.23123
ARTHRITIS RHEUM 2008
THORAT M,TURBIN D,MORIMIYA A,al. E Amplified in breast cancer 1 expression in breast cancer. vol.53, (6) 634.
10.1111/j.1365-2559.2008.03155.x
Histopathology 2008
Cuzick J Assessing risk for breast cancer.. vol.10 Suppl 4, (issue) S13.
10.1186/bcr2173
Breast Cancer Res 2008
HAN-COCK B,RADOVICH M,BADVE S,THORAT M,AZZOUZ F,SCHNEIDER B Association of single nucleotide polymorphisms in angiogenesis genes with expression of VEGF and VEGFR-2 in breast carcinoma. vol.49, (issue) 66.
doi
journal 2008
McRobbie H,Thornley S Cardiovascular Prevention (IV) The Importance of Treating Tobacco Dependence.. vol.61, (6) 620.
10.1016/S1885-5857(08)60186-3
Rev Esp Cardiol (Engl Ed) 2008
Cuzick J Chemoprevention of breast cancer.. vol.15, (1) 10.
10.1007/s12282-007-0006-z
Breast Cancer 2008
Arimidex, Tamoxifen, Alone or in Combination (ATAC) Trialists' Group null,Forbes JF,Cuzick J,Buzdar A,Howell A,Tobias JS,Baum M Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial.. vol.9, (1) 45.
10.1016/S1470-2045(07)70385-6
Lancet Oncol 2008
Singh S,Cuzick J,Ferguson S,Blake G,Truscott J,Coleman R,Eastel R,Howell A Effect of anastrozole on bone mineral density after one year of treatment: Results from bone sub-study of the International Breast Cancer Prevention Study (IBIS-II). vol.34, (issue) S53.
10.1016/j.ctrv.2008.03.037
CANCER TREATMENT REVIEWS 2008
Eastell R,Adams JE,Clack G,Howell A,Hannon RA,Cuzick J,Mackey JR,Beckmann M,Coleman R Effect of stopping anastrozole on bone mineral density: Seven-year results from the ATAC trial. vol.82, (issue) S84.
doi
CALCIFIED TISSUE INT 2008
Marchio C,Thorat M,Morimiya A,Savage K,Nakshatri H,Reis-Filho J,Badve S FOXA1: A prognostic and luminal subtype a marker in breast cancer. vol.21, (issue) 45A.
doi
MODERN PATHOLOGY 2008
Bestwick JP,Huttly WJ,Wald NJ First trimester Down's syndrome screening marker values and cigarette smoking: new data and a meta-analysis on free beta human chorionic gonadotophin, pregnancy-associated plasma protein-A and nuchal translucency.. vol.15, (4) 204.
10.1258/jms.2008.008049
J Med Screen 2008
THORAT M Five genetic variants associated with prostate cancer. vol.358, (25) 2740.
doi
N Engl J Med. 2008
THORAT M,MARCHIO C,MORIMIYA A,al. E Forkhead box A1 expression in breast cancer is associated with luminal subtype and good prognosis. vol.61, (3) 327.
10.1136/jcp.2007.052431
Journal of Clinical Pathology 2008
Wald NJ Guidance on terminology. vol.15, (1) 50.
10.1258/jms.2008.008got
Journal of Medical Screening 2008
Bhui K,Dinos S Health Beliefs and Culture Essential Considerations for Outcome Measurement. vol.16, (6) 411.
10.2165/0115677-200816060-00006
DIS MANAG HEALTH OUT 2008
Berney DM,Gopalan A,Kudahetti S,Ambroisine L,Fisher G,Kattan M,Moller H,Foster C,Reuter V,Cuzick J,Scardino P,Cooper C,Gerald W KI-67 is an independent predictor of outcome in conservatively treated clinically localised prostate cancer. vol.88, (issue) 148A.
doi
LABORATORY INVESTIGATION 2008
Berney DM,Gopalan A,Kudahetti S,Ambroisine L,Fisher G,Kattan M,Moller H,Foster C,Reuter V,Cuzick J,Scardino P,Cooper C,Gerald W Ki-67 is an independent predictor of outcome in conservatively treated clinically localised prostate cancer. vol.21, (issue) 148A.
doi
MODERN PATHOLOGY 2008
THORAT M,THORNTON H MRI breast screening.. vol.371, (9622) 1415.
10.1016/S0140-6736(08)60620-0
The Lancet 2008
Morris JK,Bestwick J,Wald NJ Multiple-marker screening for Down's syndrome: a method of assessing the statistical robustness of proposed tests.. vol.15, (2) 55.
10.1258/jms.2008.007105
J Med Screen 2008
Kattan MW,Cuzick J,Fisher G,Berney DM,Oliver T,Foster CS,Moller H,Reuter V,Fearn P,Eastham J,Scardino PT,Transatlantic Prostate Grp null Nomogram incorporating PSA level to predict cancer-specific survival for men with clinically localized prostate cancer managed without curative intent. vol.112, (1) 69.
10.1002/cncr.23106
CANCER 2008
THORAT M,MORIMIYA A,MEHROTRA S,al. E Prostanoid receptor EP1 expression in breast cancer. vol.21, (1) 15.
10.1038/modpathol.3800970
Modern Pathology 2008
Howell A,Bundred NJ,Cuzick J,Allred DC,Clarke R Response and resistance to the endocrine prevention of breast cancer.. vol.617, (issue) 201.
10.1007/978-0-387-69080-3_19
Adv Exp Med Biol 2008
Flores YN,Bishai DM,Shah KV,Lazcano-Ponce E,Lorincz A,Hernindez M,Ferris D,Salmeron J Risk factors for cervical cancer among HPV positive women in Mexico. vol.50, (1) 49.
10.1590/S0036-36342008000100011
SALUD PUBLICA MEXICO 2008
Derchain SF,Sarian LO,Naud P,Roteli-Martins C,Longatto-Filho A,Tatti S,Branca M,Erzen M,Serpa-Hammes L,Matos J,Gontijo RC,Braganca JF,Lima TP,Maeda MYS,Lorincz A,Dores GB,Costa S,Syrjanen S,Syrjanen K Safety of screening with Human papillomavirus testing for cervical cancer at three-year intervals in a high-risk population: experience from the LAMS study. vol.15, (2) 97.
10.1258/jms.2008.007061
J MED SCREEN 2008
Duffy SW,Olsen AH,Gabe R,Tabar L,Warwick J,Fielder H,Tryggvadottir L,Agbaje OF Screening opportunity bias in case-control studies of cancer screening. vol.35, (5) 537.
10.1080/02664760701835755
J APPL STAT 2008
Barnes IM,Bestwick JP,Larsen SO Setting truncation limits for marker values in medical screening (vol 14, pg 103, 2007). vol.15, (3) 159.
10.1258/jms.2008.008051
JOURNAL OF MEDICAL SCREENING 2008
Moskvina V,Farmer A,Jones IR,Brewster S,Ferrero F,Gill M,Jones LA,Maier W,Mors O,Owen MJ,Perry J,Preisig M,Rietschel M,McGuffin P,Craddock N,Korszun A Sex differences in symptom patterns of recurrent major depression in siblings. vol.25, (6) 527.
10.1002/da.20372
DEPRESS ANXIETY 2008
Dillner L,Pagliusi S,Bray F,Lorincz A,Kjaer SK,Anttila A,Iversen OE,Dillner J,Lehtinen M,Paavonen J Strengthening prevention programs to eliminate cervical cancer in the Nordic countries. vol.87, (5) 489.
10.1080/00016340801986771
ACTA OBSTET GYN SCAN 2008
Harvie M,Chapman M,Cuzick J,Flyvbjerg A,Hopwood P,Jebb S,Parfitt G,Howell A The effect of intermittent versus chronic energy restriction on breast cancer risk biomarkers in premenopausal women: a randomised pilot trial. vol.10, (issue) S27.
10.1186/bcr1937
BREAST CANCER RESEARCH 2008
McRobbie H,Thornley S The importance of treating tobacco dependence. vol.61, (6) 620.
doi
Revista Espanola de Cardiologia 2008
Thornley S,McRobbie H,Eyles H,Walker N,Simmons G The obesity epidemic: Is glycaemic index the key to unlocking a hidden addiction?. vol.71, (5) 709.
10.1016/j.mehy.2008.07.006
Medical Hypotheses 2008
Gilbert FJ,Astley SM,Boggis CRM,Mcgee MA,Griffiths PM,Duffy SW,Agbaje OF,Gillan MGC,Wilson M,Jain AK,Barr N,Beetles UM,Griffiths MA,Johnson J,Roberts RM,Deans HE,Duncan KA,Iyengar G Variable size computer-aided detection prompts and mammography film reader decisions. vol.10, (4) paginationBegin.
10.1186/bcr2137
BREAST CANCER RES 2008
Duffy SW,Nagtegaal ID,Astley SM,Gillan MGC,McGee MA,Boggis CRM,Wilson M,Beetles UM,Griffiths MA,Jain AK,Johnson J,Roberts R,Deans H,Duncan KA,Iyengar G,Griffiths PM,Warwick J,Cuzick J,Gilbert FJ Visually assessed breast density, breast cancer risk and the importance of the craniocaudal view.. vol.10, (4) R64.
10.1186/bcr2123
Breast Cancer Res 2008
THORAT M What caused the decline in US breast cancer incidence?. vol.5, (6) 314.
10.1038/ncponc1113
Nat Clin Pract Oncol. 2008